Truist Financial started coverage on shares of Summit Therapeutics (NASDAQ:SMMT – Free Report) in a report issued on Wednesday morning, MarketBeat.com reports. The brokerage issued a buy rating and a ...
A new study led by Winship Cancer Institute of Emory University and Abramson Cancer Center of University of Pennsylvania researchers demonstrates that a first-of-its-kind platform using artificial ...
Artificial intelligence can determine the course and severity of aggressive skin cancers, such as Merkel cell carcinoma (MCC), to enhance clinical decision making by generating personalized ...
Director Andrew Arno acquired 12,500 shares of the stock in a transaction dated Thursday, December 26th. The stock was purchased at an average cost of $2.11 per share, with a total value of $26,375.00 ...
The NSE Defence Index has since declined 21% from its high. Brokerage firm Antique Research says that the Indian defence story has not diminished; rather, the outlook has further improved offering ...
The company possess “build to print” and “build to specifications” capabilities and supplies high-precision and critical components to major OEMs and their licensees worldwide. Unimech’s ...
The recent trend of miniaturization across industries makes 3D printing even more attractive, and in some cases, it’s the only option to manufacture micro-sized parts with ultra-high precision. In ...